Madison drug developer raises $1.25 million
A Madison drug developer will announce Tuesday it has secured $1.25 million of funding that it will use to explore additional uses for its lead drug candidate, the Milwaukee Journal Sentinel reports. Venture Investors and the State of Wisconsin Investment Board, both in Madison, along with Rocket Venture Fund of Toledo, Ohio, participated in the funding. (JOURNAL SENTINEL, 1/11)
To access this content, you must purchase a Premium membership, or log in if you are a member.
